Physician profile
John Ballert
NPI 1831304088
$2,929.94
in general payments reported to CMS, 2019-2025
15 companies · $604 in 2025
The $604 reported for 2025 was more than what 76% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $441 · 2021: $118 · 2022: $287 · 2023: $273 · 2024: $574 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,353 · Education: $97.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,353.22 |
| Education | $97.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $895.53 | 2019-2025 | Dysport |
| Stryker Corporation | $489.46 | 2019-2022 | |
| Revance Therapeutics, INC. | $373.36 | 2024-2025 | Daxxify |
| Regeneron Healthcare Solutions, INC. | $290.52 | 2019-2025 | Dupixent |
| Genzyme Corporation | $222.80 | 2023-2025 | |
| Depuy Synthes Sales INC. | $163.74 | 2024 | Trumatch, Matrixwave |
| Allergan, INC. | $149.75 | 2022 | |
| Zimmer Biomet Holdings, INC. | $101.67 | 2019-2021 | |
| Intersect Ent, INC. | $60.28 | 2019-2021 | |
| Ethicon US, LLC | $47.92 | 2025 | Harmonic |
| Smith+Nephew, INC. | $36.92 | 2020-2024 | Halo |
| Glaxosmithkline, LLC. | $34.25 | 2025 | Nucala |
| Genentech USA, INC. | $27.98 | 2019 | |
| Abbvie INC. | $21.56 | 2023 | |
| Hologic Sales and Service, LLC | $14.20 | 2024 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ballert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.